arbekacin has been researched along with Bacteremia in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (57.14) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hagane, K; Hanaki, H; Hashimoto, T; Ikeda-Dantsuji, Y; Ishizaki, A; Kageyama, Y; Kawaguchi, T; Kawajiri, H; Ono, T; Sato, S; Sugahara, K; Sunakawa, K; Tachihara-Sato, R; Takahashi, Y; Tamura, A; Yamaguchi, Y; Yanagisawa, C; Yanagisawa, T; Yazaki, H | 1 |
Kawasumi, N; Kimura, M; Mikamo, H; Yamagishi, Y | 1 |
Imai, T; Ito, A; Matsumoto, F; Odagiri, S; Sakurai, I; Sugiyama, M; Sumitomo, M; Suzuki, M; Takahashi, K; Yoshikawa, K | 1 |
Abe, T; Fujii, R; Fujita, K; Meguro, H; Mikuni, K; Sakai, T; Sakata, Y; Tajima, T; Terashima, I; Watanabe, N | 1 |
Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Oda, S; Suzuki, Y; Yokota, N | 1 |
Ishikawa, S; Koyano, T; Morishita, Y; Noda, D; Ooki, S; Shimizu, H; Takahashi, T | 1 |
Nitta, Y; Sunakawa, K; Yokota, T | 1 |
1 review(s) available for arbekacin and Bacteremia
Article | Year |
---|---|
[MRSA septicemia caused by an infected pacemaker lead: a case report with a review of Japanese literatures].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Cardiopulmonary Bypass; Dibekacin; Drug Therapy, Combination; Female; Humans; Methicillin Resistance; Middle Aged; Minocycline; Pacemaker, Artificial; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2000 |
2 trial(s) available for arbekacin and Bacteremia
Article | Year |
---|---|
[An evaluation study on arbekacin for MRSA-infectious diseases including pneumonia, septicemia and others].
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Dibekacin; Drug Therapy, Combination; Female; Humans; Kidney; Male; Methicillin Resistance; Middle Aged; Pneumonia, Staphylococcal; Staphylococcal Infections; Staphylococcus aureus | 1994 |
[Clinical studies of arbekacin sulfate in the pediatric field].
Topics: Adolescent; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Child; Child, Preschool; Dibekacin; Female; Humans; Infant; Infant, Newborn; Male; Methicillin Resistance; Pneumonia, Staphylococcal; Staphylococcal Infections; Staphylococcus aureus; Urinary Tract Infections | 1994 |
4 other study(ies) available for arbekacin and Bacteremia
Article | Year |
---|---|
Characterization of beta-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR) in a patient with septicemia during long-term vancomycin administration.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactams; Dibekacin; Drug Therapy, Combination; Fosfomycin; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Staphylococcal Infections; Time Factors; Vancomycin; Vancomycin Resistance | 2009 |
[Clinical investigation of arbekacin sulfate based on Cmax/MIC].
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Bacteremia; Dibekacin; Gram-Positive Cocci; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Staphylococcal | 2012 |
[Antimicrobial activities of arbekacin against methicillin-resistant Staphylococcus aureus isolated from patients of a pediatrics ward].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Child; Dibekacin; Humans; Kanamycin Resistance; Methicillin Resistance; Pneumonia; Respiratory System; Staphylococcal Infections; Staphylococcus aureus | 1993 |
[MRSA infections in neonates and premature infants].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Dibekacin; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1992 |